Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christine Guo Lian, M.D.

Co-Author

This page shows the publications co-authored by Christine Lian and Martin Mihm.
Connection Strength

1.439
  1. Novel genetic mutations in a sporadic port-wine stain. JAMA Dermatol. 2014 Dec; 150(12):1336-40.
    View in: PubMed
    Score: 0.599
  2. 5-Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasms. J Cutan Pathol. 2017 Mar; 44(3):249-255.
    View in: PubMed
    Score: 0.174
  3. Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell/nevoid subpopulations and assists in microstaging of human melanoma. Oncotarget. 2015 Nov 10; 6(35):37995-8004.
    View in: PubMed
    Score: 0.160
  4. Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas. Clin Epigenetics. 2015; 7:59.
    View in: PubMed
    Score: 0.155
  5. Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors. Mod Pathol. 2014 Jul; 27(7):936-44.
    View in: PubMed
    Score: 0.141
  6. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell. 2012 Sep 14; 150(6):1135-46.
    View in: PubMed
    Score: 0.128
  7. Decreased tumor-infiltrating lymphocytes in nodular melanomas compared with matched superficial spreading melanomas. Melanoma Res. 2016 10; 26(5):524-7.
    View in: PubMed
    Score: 0.043
  8. Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth. Cell. 2015 Sep 10; 162(6):1242-56.
    View in: PubMed
    Score: 0.039
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.